Us Bancorp \De\ Geron Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Geron Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 18,296 shares of GERN stock, worth $62,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,296

Previous 10,867 68.36%

Holding current value

$62,206

Previous $46,000 80.43%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$4.17 - $4.99 $30,978 - $37,070	7,429 Added 68.36%	18,296 $83,000
Q2 2024 Aug 06, 2024	BUY	$3.1 - $5.09 $19,099 - $31,359	6,161 Added 130.92%	10,867 $46,000
Q1 2024 May 07, 2024	BUY	$1.75 - $3.44 $1,235 - $2,428	706 Added 17.65%	4,706 $15,000
Q3 2023 Nov 03, 2023	BUY	$2.11 - $3.28 $4,220 - $6,560	2,000 Added 100.0%	4,000 $8,000
Q1 2022 May 11, 2022	SELL	$0.99 - $1.6 $133 - $216	-135 Reduced 6.32%	2,000 $3,000
Q4 2021 Feb 11, 2022	BUY	$1.22 - $1.72 $1,384 - $1,952	1,135 Added 113.5%	2,135 $2,000
Q3 2021 Nov 10, 2021	SELL	$1.2 - $1.5 $384 - $480	-320 Reduced 24.24%	1,000 $1,000
Q2 2021 Aug 05, 2021	BUY	$1.25 - $1.83 $400 - $585	320 Added 32.0%	1,320 $2,000
Q1 2021 Apr 28, 2021	SELL	$1.52 - $2.1 $1,088 - $1,503	-716 Reduced 41.72%	1,000 $2,000
Q4 2020 Feb 04, 2021	BUY	$1.55 - $2.05 $1,109 - $1,467	716 Added 71.6%	1,716 $3,000
Q2 2020 Aug 07, 2020	SELL	$1.05 - $2.18 $3,150 - $6,540	-3,000 Reduced 75.0%	1,000 $2,000
Q1 2020 May 13, 2020	BUY	$0.89 - $1.49 $890 - $1,490	1,000 Added 33.33%	4,000 $5,000
Q2 2019 Aug 13, 2019	SELL	$1.37 - $2.02 $20,550 - $30,300	-15,000 Reduced 83.33%	3,000 $4,000
Q4 2018 Feb 13, 2019	SELL	$0.98 - $1.85 $6,100 - $11,516	-6,225 Reduced 25.7%	18,000 $18,000
Q1 2018 May 08, 2018	BUY	$1.81 - $5.98 $2,217 - $7,325	1,225 Added 5.33%	24,225 $103,000
Q3 2017 Nov 13, 2017	BUY	$1.99 - $2.65 $45,770 - $60,950	23,000	23,000 $50,000

Others Institutions Holding GERN

# of Institutions

274

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.28B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account